Gansu Longshenrongfa Pharmaceutical Industry Co Ltd. Stock Analysis 300534.SZ

Gansu Longshenrongfa Pharmaceutical Industry Co., Ltd. engages in the research, development, and sale of medical and healthcare products. The company is headquartered in Lanzhou, Gansu and currently employs 641 full-time employees. The company went IPO on 2016-09-13. The firm produces various dosage forms including pills, oral solutions, tablets, hard capsules, and films. The main products include Xuanfei Zhike Mixture, Yuanhu Zhitong Pills, Suanzaoren Oil Pills, Berberine Tannic Acid Film, Qiwei Wenyang Capsules, Ma Xing Zhike Capsules, Compound Danshen Tablets, Xiaoshuan Tongluo Tablets, Sanqi Shangyao Tablets, Huangqi Danggui Capsules, and hemodialysis concentrate. The firm also provides consulting, testing and inspection, technical services, and property leasing. Its products are sold in both domestic and international markets.